FEDERATED HERMES, INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$660,225
-34.2%
18,473
-30.5%
0.00%
-33.3%
Q4 2022$1,003,889
-13.2%
26,579
+1.7%
0.00%0.0%
Q3 2022$1,156,000
+14.6%
26,127
-4.1%
0.00%0.0%
Q2 2022$1,009,000
+48.4%
27,237
+48.3%
0.00%
+50.0%
Q1 2022$680,000
+427.1%
18,362
+331.7%
0.00%
Q4 2021$129,000
-9.8%
4,2530.0%0.00%
Q3 2021$143,000
-12.3%
4,253
+4.0%
0.00%
Q2 2021$163,000
-62.2%
4,090
-46.3%
0.00%
-100.0%
Q4 2020$431,000
+19.4%
7,622
+0.2%
0.00%0.0%
Q3 2020$361,000
-22.0%
7,604
-3.2%
0.00%0.0%
Q2 2020$463,000
-83.2%
7,856
-86.5%
0.00%
-87.5%
Q1 2020$2,753,000
+405.1%
58,235
+545.8%
0.01%
+700.0%
Q4 2019$545,000
+429.1%
9,018
+424.6%
0.00%
Q3 2019$103,000
-98.8%
1,719
-98.7%
0.00%
-100.0%
Q2 2019$8,408,000
-61.3%
130,823
-51.2%
0.02%
-63.0%
Q1 2019$21,744,000
+198.6%
267,878
+98.9%
0.05%
+170.0%
Q4 2018$7,282,000
+710.0%
134,700
+662.6%
0.02%
+566.7%
Q2 2017$899,000
-64.1%
17,664
-71.7%
0.00%
-57.1%
Q1 2017$2,507,000
+162.0%
62,358
+211.8%
0.01%
+133.3%
Q4 2016$957,000
+30.6%
20,0000.0%0.00%
+50.0%
Q3 2016$733,000
+65.8%
20,000
+5.5%
0.00%
+100.0%
Q2 2016$442,000
+44100.0%
18,966
+379220.0%
0.00%
Q4 2015$1,00050.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders